Liquid chromatography with multi-channel electrochemical detection for the determination of epigallocatechin gallate in rat plasma utilizing an automated blood sampling device

被引:22
作者
Long, H [1 ]
Zhu, YX [1 ]
Cregor, M [1 ]
Tian, FF [1 ]
Coury, L [1 ]
Kissinger, CB [1 ]
Kissinger, PT [1 ]
机构
[1] Bioanalyt Syst Inc, W Lafayette, IN 47906 USA
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2001年 / 763卷 / 1-2期
关键词
epigallocatechin gallate;
D O I
10.1016/S0378-4347(01)00365-6
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A liquid chromatography method with multi-channel electrochemical detection was developed for the determination of epigallocatechin gallate (EGCG) in rat plasma. After administration of EGCG, blood samples were periodically collected by Culex (an automated blood sampling robot). EGCG was extracted from 50 mul of diluted blood (blood and saline at a ratio of 1:1) with ethyl acetate. Chromatographic separation was achieved within 10 min using a C-8 (150X4.6 mm) 5 mum column with a mobile phase containing 20 mM sodium monochloroacetate, pH 2.8 and 12% acetonitrile at a flow-rate of 1.2 ml/min. A four-channel detector with glassy carbon electrodes was used with applied potentials of +700, 600, 500, 400 mV vs. Ag/AgCl. The limit of detection was 2 ng/ml at a signal-to-noise ratio of 3:1 and the limit of quantitation was 5 ng/ml. The calibration curve was linear over the range of 5-800 ng/ml. The intra- and inter-assay precisions were in the range of 1.3-4.5% and 2.2-4.4%, respectively, Using this method it was possible to determine plasma concentration following a single dose of EGCG to rats with good accuracy and precision. Thus the pharmacokinetic properties of EGCG in rats can be examined for intravenous, intraperitoneal and oral dosing. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:47 / 51
页数:5
相关论文
共 26 条
[1]  
Chen LS, 1997, DRUG METAB DISPOS, V25, P1045
[2]   Green tea epigallocatechin gallate shows a pronounced growth inhibitory effect on cancerous cells but not on their normal counterparts [J].
Chen, ZP ;
Schell, JB ;
Ho, CT ;
Chen, KY .
CANCER LETTERS, 1998, 129 (02) :173-179
[3]   Pharmacokinetics of the green tea derivative, EGCG, by the topical route of administration in mouse and human skin [J].
Dvorakova, K ;
Dorr, RT ;
Valcic, S ;
Timmermann, B ;
Alberts, DS .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1999, 43 (04) :331-335
[4]   ANTICARCINOGENIC EFFECTS OF (-)-EPIGALLOCATECHIN GALLATE [J].
FUJIKI, H ;
YOSHIZAWA, S ;
HORIUCHI, T ;
SUGANUMA, M ;
YATSUNAMI, J ;
NISHIWAKI, S ;
OKABE, S ;
NISHIWAKIMATSUSHIMA, R ;
OKUDA, T ;
SUGIMURA, T .
PREVENTIVE MEDICINE, 1992, 21 (04) :503-509
[5]   Effects of green tea catechins on the progression or late promotion stage of mammary gland carcinogenesis in female Sprague-Dawley rats pretreated with 7,12-dimethylbenz(a)anthracene [J].
Hirose, M ;
Mizoguchi, Y ;
Yaono, M ;
Tanaka, H ;
Yamaguchi, T ;
Shirai, T .
CANCER LETTERS, 1997, 112 (02) :141-147
[6]   INHIBITORY EFFECT OF TOPICAL APPLICATION OF A GREEN TEA POLYPHENOL FRACTION ON TUMOR INITIATION AND PROMOTION IN MOUSE SKIN [J].
HUANG, MT ;
HO, CT ;
WANG, ZY ;
FERRARO, T ;
FINNEGANOLIVE, T ;
LOU, YR ;
MITCHELL, JM ;
LASKIN, JD ;
NEWMARK, H ;
YANG, CS ;
CONNEY, AH .
CARCINOGENESIS, 1992, 13 (06) :947-954
[7]   Continuous blood withdrawal as a rapid screening method for determining clearance and oral bioavailability in rats [J].
Humphreys, WG ;
Obermeier, MT ;
Morrison, RA .
PHARMACEUTICAL RESEARCH, 1998, 15 (08) :1257-1261
[8]   Modulation of endocrine systems and food intake by green tea epigallocatechin gallate [J].
Kao, YH ;
Hiipakka, RA ;
Liao, SS .
ENDOCRINOLOGY, 2000, 141 (03) :980-987
[9]   MEASUREMENT OF SULFAMETHIZOLE CLEARANCE RATE BY NONTHROMBOGENIC CONSTANT BLOOD-WITHDRAWAL SYSTEM [J].
KOWARSKI, CR ;
GIANCATARINO, C ;
KREAMER, R ;
BRECHT, D ;
KOWARSKI, A .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1976, 65 (03) :450-452
[10]   CONSTANT BLOOD WITHDRAWAL METHOD FOR AREA UNDER PLASMA CONCENTRATION-TIME CURVE [J].
KOWARSKI, CR ;
KOWARSKI, AA .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1978, 67 (06) :875-876